Bellafante Daniele, Gioia Stefania, Faccioli Jessica, Riggio Oliviero, Ridola Lorenzo, Nardelli Silvia
Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Roma, Italy.
J Clin Med. 2023 Feb 2;12(3):1187. doi: 10.3390/jcm12031187.
Hepatic encephalopathy (HE) is a common complication in patients with advanced liver disease. It is a brain dysfunction characterized by neurological and psychiatric symptoms that significantly affects quality of life, morbidity and mortality of patients. HE has various precipitants that can potentially promote its onset, alone or in combination. Among the historically well-known precipitants, such as infections, gastrointestinal bleeding, dehydration, electrolyte disorders and constipation, recent studies have highlighted the role of malnutrition and portosystemic shunts as new precipitating factors of HE. The identification, management and correction of these factors are fundamental for effective HE treatment, in addition to pharmacological therapy with non-absorbable disaccharides and/or antibiotics.
肝性脑病(HE)是晚期肝病患者常见的并发症。它是一种以神经和精神症状为特征的脑功能障碍,严重影响患者的生活质量、发病率和死亡率。HE有多种促发因素,这些因素单独或共同作用都可能促使其发病。在诸如感染、胃肠道出血、脱水、电解质紊乱和便秘等历史上广为人知的促发因素中,最近的研究强调了营养不良和门体分流作为HE新的促发因素的作用。除了使用不可吸收的二糖和/或抗生素进行药物治疗外,识别、管理和纠正这些因素对于有效治疗HE至关重要。